Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Karyotyping

Karyotyping

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Autologous Bone Marrow Transplantation Followed by Involved Field Radiotherapy in Patients with Relapsed or Refractory Hodgkin's Disease.

Leukemia & lymphoma·2016

Same author

Late Relapse in Hodgkin's Disease: Report of Five Cases and a Review of the Literature.

Leukemia & lymphoma·2016

Same author

Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B.

Leukemia & lymphoma·2016

Same author

Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients.

Leukemia & lymphoma·2016

Same author

HDS: Establishment of a New Cell Line from a Hairy Cell Leukemia Patient with Resistance to Alpha-Interferon Therapy.

Leukemia & lymphoma·2016

Same author

The Treatment of Hairy Cell Leukemia: A Review.

Leukemia & lymphoma·2016

Search research articles

Related Experiment Video

Updated: Mar 17, 2026

Chromosome Preparation From Cultured Cells

Chromosome Preparation From Cultured Cells

Published on: January 28, 2014

Familial Lymphoproliferative Disorders with Chromosomal Fragile Site Analysis.

J A Moormeier¹, M E Neilly¹, J W Vardiman²

¹a Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, Illinois, 60637, USA.

Leukemia & Lymphoma

|July 28, 2016

Summary

This study found elevated common fragile sites in a family with clustered B-cell lymphoproliferative disorders. This suggests a potential genetic susceptibility to mutagens contributing to their cancers.

Keywords:

Chromosomal fragile sites Familial lymphoid neoplasms Hairy cell leukemia Lymphoproliferative disorders Non-Hodgkin's lymphoma

More Related Videos

Capturing Common Fragile Site Breaks by Native γH2A.X ChIP

Capturing Common Fragile Site Breaks by Native γH2A.X ChIP

Published on: January 24, 2025

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH

Published on: August 19, 2014

Related Experiment Videos

Last Updated: Mar 17, 2026

Chromosome Preparation From Cultured Cells

Chromosome Preparation From Cultured Cells

Published on: January 28, 2014

Capturing Common Fragile Site Breaks by Native γH2A.X ChIP

Capturing Common Fragile Site Breaks by Native γH2A.X ChIP

Published on: January 24, 2025

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH

Published on: August 19, 2014

Area of Science:

Genetics
Oncology
Molecular Biology

Background:

B-cell lymphoproliferative disorders, including hairy cell leukemia and large cell lymphoma, can cluster within families.
The role of chromosomal fragile sites in cancer development is an area of ongoing research.
Understanding genetic predispositions is crucial for cancer etiology.

Purpose of the Study:

To investigate chromosomal fragile site expression in a family with multiple B-cell lymphoproliferative disorders.
To determine if rare or common fragile sites are associated with the observed cancer clustering.
To explore potential links between fragile site expression and mutagenic susceptibility.

Main Methods:

Analysis of chromosomal fragile sites (rare and common) in peripheral blood lymphocytes.
Comparison of fragile site expression levels between affected family members and healthy controls.
Statistical analysis to assess the significance of observed differences.

Main Results:

No significant difference in the number of rare fragile sites between patients and controls.
Significantly elevated expression of common fragile sites in all affected family members compared to controls.
Hairy cell leukemia and large cell lymphoma were diagnosed in three family members within nine months.

Conclusions:

Elevated common fragile site expression may indicate a genetic susceptibility to mutagenic damage in this family.
Environmental mutagen exposure is a potential contributing factor to the temporal clustering of malignancy.
Further research is needed to elucidate the relationship between common fragile sites and cancer development.